Received grant in 2019
DCCC has funded 198,000 DKK to the project.
Denmark was one of the first countries to introduce reflex testing for mismatch repair (MMR). The outcome and efficacy of the program have, however, not been evaluated despite a 45.000 cases analysed to a cost of about 180 MDKK. This multidisciplinary group of health professionals and researchers plans to design a possibility to evaluate the clinical significance of MMR analyses, primarily in colorectal cancer with exploratory studies in endometrial cancer and in upper urothelial cancer.
Multidisciplinary organisation
Danish Colorectal Cancer Group (DCCG), Danish Urology Cancer Group (DUCG), Danish Gynecological Cancer Group (DGCG)
Project stakeholders
- Mef Nilbert, MD, PhD, Professor, Clinical Research Centre, Copenhagen University Hospital, Hvidovre and the Danish Cancer Society Research Center. Primary contact, Mail: nilbert@cancer.dk
- Christina Therkildsen, Senior Scientist, the HNPCC-register, Clinical Research Centre, Copenhagen University Hospital, Hvidovre
- Lars-Henrik Jensen, Oncologist, Vejle Hospital
- Lene Iversen, Professor of Surgery, Department of Clinical Medicine, Aarhus University Hospital
- Peter Ingeholm, Pathologist, Representative from the DCCG
- Charlotte Kvist Lautrup, Clinical Geneticist, Aalborg University Hospital
- Louise Klarskov, Pathologist, Copenhagen University Hospital, Herlev, Representative from the HNPCC register steering group
- Zoreh Ketabi, Gynecologist, Copenhagen University Hospital, Rigshospitalet, Representative from the DGCG
- Kenneth Steven, Urologist, Copenhagen University Hospital, Herlev